The Ak mouse strain, initiated by Furth in 1933 (1) , has played a central role in leukemia research. Greater than 80% of mice of this strain develop leukemia of lymphoid type by 10 months of age. Several key findings have come from the study of Ak mice and the AKR substrain, e.g., recognition that the thymus is essential for leukemia development (2) , identification of the first mammalian leukemia virus (3) , evidence that the leukemia virus is integrated in the host genome and is transmitted as a Mendelian characteristic (4), etc. Although much has been learned about genetic and environmental factors that influence expression of the leukemia virus genome and the development of leukemia, the critical events whereby infected lymphoid cells are transformed into leukemic cells are unknown. Immunological analysis has identified a series of antigens related to the leukemia virus (5) . As these are found in infected "normal" cells as well as in leukemia cells, none of the antigens discovered thus far is transformation-specific, i.e., found only in or on leukemia cells. Biochemical analysis has similarly failed to disclose qualitative differences between normal and leukemia cells.
Chromosome analysis of AKR leukemia performed by Stich and his colleagues in 1959 revealed that a proportion of the leukemia cells had an extra chromosome (6). This remarkable observation, which was confirmed by others (7, 8) , could not be extended at that time because of the well-known difficulty of distinguishing mouse chromosomes one from another. The advent of new fluorescence and Giemsa staining methods (9-11) whereby chromosomes may be individualized by differential banding patterns along their lengths now allows the investigator to identify the 20 chromosome pairs in the mouse (12, 13) and to assign, by means of translocation stocks, linkage groups to particular chromosomes (14, 15) . These technical advances prompted us to reexamine the karyotype of AKR leukemias to see whether a consistent chromosomal abnormality might accompany leukemogenesis in this strain. 15 and chromosome 12 are among those exhibiting this constriction. Clearly, the relation between chromosomal trisomy of malignant cells and abnormalities in nucleolar development and function needs further study.
Is trisomy characteristic of any human cancer? The highly consistent abnormality of chronic myelocytic leukemia, the Philadelphia chromosome (31), does not apparently involve trisomy; the abnormality has been recognized recently as a translocation between the longer arms of chromosomes 22 and 9 (32, 33) . Occurrence of trisomy 8 in bone marrow of patients with myeloproliferative disorders or acute myeloblastic leukemia (34, 35) and trisomy 9 in acute myelomonoblastic leukemia (36) have been reported for the small number of Cgroup trisomies so far investigated by chromosome banding procedures. An isochromosome of the long arm of 17, resulting in effective trisomy of that arm, has been described for several cases of chronic myelocytic leukemia during blastic crisis (31, 37) . In one investigation an additional terminal band on chromosome 14 was found in 10 out of 12 cases of Burkitt's lymphoma (38) . Another instance of specific chromosomal abnormality is manifested as chromosome loss rather than either translocation or gain, i.e., deletion or loss of chromosome 22 as documented in a recent survey (39) of 105 meningiomas. However, at least from studies to date, most human cancers have not shown the consistent chromosomal patterns that have emerged from the analysis of primary rat, hamster, and mouse tumors.
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